Journal Mobile Options
Table of Contents
Vol. 13, No. 1, 2006
Issue release date: August 2006
Neuroimmunomodulation 2006;13:28–35
(DOI:10.1159/000093271)

Estradiol, but Not Dehydroepiandrosterone, Decreases Parasitemia and Increases the Incidence of Cerebral Malaria and the Mortality in Plasmodium berghei ANKA-Infected CBA Mice

Libonati R.M.F. · Cunha M.G. · Souza J.M. · Santos M.V.N. · Oliveira S.G. · Daniel-Ribeiro C.T. · Carvalho L.J.M. · do Nascimento J.L.M.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Objective: The effect of castration and subsequent replacement of dehydroepiandrosterone (DHEA) or estradiol on parasitemia, mortality and incidence of cerebral malaria (CM) was evaluated in CBA mice infected with Plasmodium berghei ANKA. Methods: Female mice were castrated, and groups of 12–15 animals received daily injections of DHEA, estradiol or saline. Four days after the start of treatment, mice were inoculated with 1 × 106P. berghei ANKA-parasitized erythrocytes. DHEA treatment was continued during the 5 days after infection, and estradiol was administered during the follow-up. Parasitemia was evaluated daily in Giemsa-stained blood smears. Signs of CM were determined by the manifestation of coma, limb paralysis and/or convulsions. Plasma TNF-α levels were evaluated by sandwich ELISA. Nitric oxide synthase (NOS) activity in the brain of moribund mice was measured by the method of Bredt and Snyder. Results: In non-castrated infected mice, the incidence of CM was 50%, and plasma TNF-α increased and brain NOS activity decreased compared to non-infected controls. Castration had no major effect on the parameters analyzed (parasitemia, mortality, CM incidence, TNF-α levels or NOS activity). Estradiol replacement caused a decrease in parasitemia but resulted in higher CM incidence and faster mortality, with an increase in NOS activity. Conclusions: Estradiol modulated the immune response of P. berghei ANKA-infected CBA mice, decreasing parasitemia and increasing NOS activity, and impacted negatively on survival and CM incidence, showing that neuroimmunoendocrine interactions are important in the physiopathogenesis of malaria infections.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Grossman CJ: Regulation of the immune system by sex steroids. Endocr Rev 1984;5:435–455.
  2. Roberts CW, Walker W, Alexander J: Sex-associated hormones and immunity to protozoan parasites. Clin Microbiol Rev 2001;14:476–488.
  3. Olsen NJ, Kovacs WJ: Gonadal steroids and immunity. Endocr Rev 2005;17:369–384.
  4. Perignon JL, Druilhe P: Immune mechanisms underlying the premunition against Plasmodium falciparum malaria. Mem Inst Oswaldo Cruz 1994;89:51–53.
  5. Baird JK: Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol Today 1995;11:105–111.
  6. Baird JK, Pornomo, Basri H, Bangs MJ, Andersen EM, Jones TR, Masbar S, Harjo Suwarno S, Subianto B, Arbani PR: Age-specific prevalence of Plasmodium falciparum among six populations with limited histories of exposure to endemic malaria. Am J Trop Med Hyg 1993;49:707–719.
  7. Kurtis JD, Mtalib R, Onyango, Duffy PE: Human resistance to Plasmodium falciparum increases during puberty and is predicted by dehydroepiandrosterone sulfate levels. Infect Immun 2001;69:123–128.
  8. Leenstra T, Kuile FO, Kariuki SK, Nixon CP, Oloo AJ, Kager PA, Kurtis JD: Dehydroepiandrosterone sulfate levels associated with decreased malaria parasite density and increased hemoglobin concentration in pubertal girls from western Kenya. J Infect Dis 2003;188:297–304.
  9. Brabin BJ, Johnson PM: Placental malaria and pre-eclampsia through the looking glass backwards? J Reprod Immunol 2005;65:1–15.
  10. Martinez-Espinosa FE, Daniel-Ribeiro CT, Alecrim WD: Malaria during pregnancy in a reference center from the Brazilian Amazon: unexpected increase in the frequency of Plasmodium falciparum infections. Mem Inst Oswaldo Cruz 2004;99:19–21.
  11. Craig AG: Pregnancy-associated malaria – on the brink? Trends Parasitol 2004;20:201–204.
  12. Guyatt HL, Snow RW: Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev 2004;17:760–769.
  13. Van Geertruyden JP, Thomas F, Erhart A, D’Alessandro U: The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg 2004;71:35–40.
  14. Roberts CW, Satoskar A, Alexander J: Sex steroids, pregnancy-associated hormones and immunity to parasite infection. Parasitol Today 1996;12:382–388.
  15. Bouyou-Akotet MK, Issifou S, Meye JF, Kombila M, Ngou-Milama E, Luty AJ, Kremsner PG, Mavongou E: Depressed natural killer cell cytotoxicity against Plasmodium falciparum-infected erythrocytes during first pregnancies. Clin Infect Dis 2004;38:342–347.
  16. Freilich D, Ferris S, Wallace M, Leach L, Kallen A, Frincke J, Ahlem C, Hacker M, Nelson D, Herbert J: 16α-Bromoepiandrosterone, a dehydroepiandrosterone (DHEA) analogue, inhibits Plasmodium falciparum and Plasmodium berghei growth. Am J Trop Med Hyg 2000;63:280–283.
  17. Ayi K, Giribaldi G, Skorokhod A, Schwarzer E, Prendergast PT, Arese P: 16α-Bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: a novel mechanism for antimalarial activity. Antimicrob Agents Chemother 2002;46:3180–3184.
  18. Benten WP, Wunderlich F, Herrmann R, Kuhn-Velten WN: Testosterone-induced compared with oestradiol-induced immunosuppression against Plasmodium chabaudi malaria. J Endocrinol 1993;139:487–494.
  19. Wunderlich F, Benten WP, Lieberherr M, Guo Z, Stamm O, Wrehlke C, Sekeris CE, Mossmann H: Testosterone signaling in T cells and macrophages. Steroids 2002;67:535–538.
  20. Zhang Z, Chen L, Saito S, Kanagawa O, Sendo F: Possible modulation by male sex hormone of Th1/Th2 function in protection against Plasmodium chabaudi chabaudi AS infection in mice. Exp Parasitol 2000;96:121–129.
  21. Wunderlich F, Marinovski P, Benten WP, Schmitt-Wrede HP, Mossmann H: Testosterone and other gonadal factor(s) restrict the efficacy of genes controlling resistance to Plasmodium chabaudi malaria. Parasite Immunol 1991;13:357–367.
  22. Mossmann H, Benten WP, Galanos C, Freudenberg M, Kuhn-Velten WN, Reinauer H, Wunderlich F: Dietary testosterone suppresses protective responsiveness to Plasmodium chabaudi malaria. Life Sci 1997;60:839–848.
  23. Benten WP, Ulrich P, Kuhn-Velten WN, Vohr HW, Wunderlich F: Testosterone-induced susceptibility to Plasmodium chabaudi malaria: persistence after withdrawal of testosterone. J Endocrinol 1997;153:275–281.
  24. Benten WP, Wunderlich F, Mossmann H: Plasmodium chabaudi: estradiol suppresses acquiring, but not once-acquired immunity. Exp Parasitol 1992;75:240–247.
  25. Mackintosh CL, Beeson JG, Marsh K: Clinical features and pathogenesis of severe malaria. Trends Parasitol 2004;20:597–603.
  26. Clark IA, Alleva LM, Mills AC, Cowden WB: Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev 2004;17:509–539.
  27. Hunt NH, Grau GE: Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol 2003;24:491–499.
  28. Carvalho LJ, Lenzi HL, Pelajo-Machado M, Oliveira DN, Daniel-Ribeiro CT, Ferreira-da-Cruz MF: Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes. Exp Parasitol 2000;95:1–7.
  29. de Souza JB, Riley EM: Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect 2002;4:291–300.
  30. Bredt DS, Snyder SH: Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989;86:9030–9033.
  31. Clark IA, Rockett KA, Cowden WB: Proposed link between cytokines, nitric oxide and human cerebral malaria. Parasitol Today 1991;7:205–207.
  32. Clark IA, Alleva LM, Mills AC, Cowden WB: Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev 2004;17:509–539.
  33. al-Yaman FM, Mokela D, Genton B, Rockett KA, Alpers MP, Clark IA: Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea. Trans R Soc Trop Med Hyg 1996;90:270–273.
  34. Weiss G, Thuma PE, Biemba G, Mabeza G, Werner ER, Gordeuk VR: Cerebrospinal fluid levels of biopterin, nitric oxide metabolites, and immune activation markers and the clinical course of human cerebral malaria. J Infect Dis 1998;177:1064–1068.
  35. Maneerat Y, Viriyavejakul P, Punpoowong B, Jones M, Wilairatana P, Pongponratn E, Turner GD, Udomsangpetch R: Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria. Histopathology 2000;37:269–277.
  36. Clark IA, Rockett KA, Burgner D: Genes, nitric oxide and malaria in African children. Trends Parasitol 2003;19:335–337.
  37. Taylor AM, Day NP, Sinh DX, Loc PP, Mai TT, Chau TT, Phu NH, Hien TT, White NJ: Reactive nitrogen intermediates and outcome in severe adult malaria. Trans R Soc Trop Med Hyg 1998;92:170–175.
  38. Levesque MC, Hobbs MR, Anstey NM, Vaughn TN, Chancellor JA, Pole A, Perkins DJ, Misukonis MA, Chanock SJ, Granger DL, Weinberg JB: Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. J Infect Dis 1999;180:1994–2002.
  39. Dondorp AM, Planche T, de Bel EE, Angus BJ, Chotivanich KT, Silamut K, Romijn JA, Ruangveerayuth R, Hoek FJ, Kager PA, Vreeken J, White NJ: Nitric oxides in plasma, urine, and cerebrospinal fluid in patients with severe falciparum malaria. Am J Trop Med Hyg 1998;59:497–502.
  40. Chiwakata CB, Hemmer CJ, Dietrich M: High levels of inducible nitric oxide synthase mRNA are associated with increased monocyte counts in blood and have a beneficial role in Plasmodium falciparum malaria. Infect Immun 2000;68:394–399.
  41. Pino P, Vouldoukis I, Dugas N, Conti M, Nitcheu J, Traore B, Danis M, Dugas B, Mazier D: Induction of the CD23/nitric oxide pathway in endothelial cells downregulates ICAM-1 expression and decreases cytoadherence of Plasmodium falciparum-infected erythrocytes. Cell Microbiol 2004;6:839–848.
  42. Kremsner PG, Nussler A, Neifer S, Chavez MF, Bienzle U, Senaldi G, Grau GE: Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: no relevance to the development of experimental cerebral malaria. Immunology 1993;78:286–290.
  43. Asensio VC, Oshima H, Falanga PB: Plasmodium berghei: is nitric oxide involved in the pathogenesis of mouse cerebral malaria? Exp Parasitol 1993;77:111–117.
  44. Favre N, Ryffel B, Rudin W: The development of murine cerebral malaria does not require nitric oxide production. Parasitology 1999;118:135–138.
  45. Prada J, Muller S, Bienzle U, Kremsner PG: Upregulation of reactive oxygen and nitrogen intermediates in Plasmodium berghei infected mice after rescue therapy with chloroquine or artemether. J Antimicrob Chemother 1996;38:95–102.
  46. Hanum PS, Hayano M, Kojima S: Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. Int Immunol 2003;15:633–640.
  47. Muniz-Junqueira MI, Silva FO, de Paula-Junior FR, Tosta CE: Thalidomide influences the function of macrophages and increases the survival of Plasmodium berghei-infected CBA mice. Acta Trop 2005;94:128–138.
  48. Pasquet JPEE, Zou MH, Ulrich V: Peroxynitrite inhibition of nitric oxide synthases. Biochimie 1996;78:785–791.
  49. Robinson VK, Sato E, Nelson DK, Cambi SL, Robbins RA, Hoyt JC: Peroxynitrite inhibits inducible (type 2) nitric oxide synthase in murine lung epithelial cells in vitro. Free Radic Biol Med 2001;30:986–991.
  50. Chao CC, Anderson WR, Hu S, Gekker G, Martella A, Peterson PK: Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin Immunol Immunopathol 1993;67:178–183.
  51. Garcia I, Guler R, Vesin D, Olleros ML, Vassali P, Chvatchko Y, Jacobs M, Ryffel B: Lethal Mycobacterium bovis Bacillus Calmette Guérin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2. Lab Invest 2000;80:1385–1397.
  52. Struik SS, Riley EM: Does malaria suffer from lack of memory? Immunol Rev 2004;201:268–290.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50